Skip to main content

Mesenchymal Stem Cell Therapy for Osteoarthritis: Practice and Possible Promises

  • Chapter
  • First Online:
Cell Biology and Translational Medicine, Volume 16

Abstract

Osteoarthritis (OA) is a common progressively degenerative joint disease that affects more than 300 million people worldwide. OA is manifested by articular cartilage degradation, chronic pain, deformity, functional disability, and decreased quality of life. A real challenge in OA management is the lack of an effective cure because exiting therapeutics often provide symptom control rather than disease modification; therefore, they fail to prevent disease progression. The inadequate treatments for OA management have encouraged researchers to study mesenchymal stem cells (MSCs) as an investigational treatment for OA. MSCs are a promising tool for OA because of their availability; expand cultivation and multi-lineage differentiation capacity as well as well-documented paracrine function have made MSCs a promising tool in this field. Accordingly, MSCs application has been successfully utilized in a broad range of pre-clinical OA animal models as well as clinical studies with the aim of cartilage repair which had not previously been achieved using classical treatments. Here, the brief scientific review of MSC role in the control of OA as well as the proposed mechanisms are discussed. We provide an insight into the last 10 years’ studies conducted on preclinical and clinical OA treatment as well as future opportunities in OA management strategies employing MSCs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

3D:

Three-dimensional

ACI:

Autologous chondrocyte implantation

ACLT:

Anterior cruciate ligament amputation

ADMSCs:

Adipose-derived mesenchymal stem cells

BMSCs:

Bone marrow mesenchymal stem cells

CDMP1:

Cartilage-derived morphogenetic protein 1

CTGF:

Connective tissue growth factor

CXCR4:

C-X-C chemokine receptor 4

ECM:

Extracellular matrix

EGF:

Epidermal growth factor

ESWT:

Extracorporeal shockwave therapy

FGF:

Fibroblast growth factor

FGFR:

Fibroblast growth factor receptor

GAG:

Glycosaminoglycan

GO:

Graphene oxide

HA:

Hyaluronic acid

IA:

Intra-articular

IGF-1:

Insulin-like growth factor 1

IV:

Intravenous

KOOS:

Knee Injury and Osteoarthritis Outcome Score

MIA:

Monosodium iodoacetate

MRI:

Magnetic resonance imaging

MSCs:

Mesenchymal stem cells

NPs:

Nanoparticles

OA:

Osteoarthritis

PBS:

Phosphate-buffered saline

PGE2:

Prostaglandin E2

PLMSCs:

Placenta-derived mesenchymal stem cells

PRP:

Platelet-rich plasma

TGFβ:

Transforming growth factor beta

UCMSCs:

Umbilical cord mesenchymal stem cells

VAS:

Visual analog scale

VEGF1:

Vascular endothelial growth factor1

WJMSCs:

Wharton’s jelly mesenchymal stem cells

WOMAC:

Western Ontario and McMaster Universities Osteoarthritis Index

μCT:

Micro-CT

References

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Samaneh Hosseini or Mohamdreza Baghaban Eslaminejad .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nasiri, N., Nateghi, R., Zarei, F., Hosseini, S., Eslaminejad, M.B. (2021). Mesenchymal Stem Cell Therapy for Osteoarthritis: Practice and Possible Promises. In: Turksen, K. (eds) Cell Biology and Translational Medicine, Volume 16. Advances in Experimental Medicine and Biology(), vol 1387. Springer, Cham. https://doi.org/10.1007/5584_2021_695

Download citation

Publish with us

Policies and ethics